Optical Coherence Tomography Angiography to Distinguish Changes of Choroidal Neovascularization after Anti-VEGF Therapy: Monthly Loading Dose versus Pro Re Nata Regimen [PDF]
Journal of Ophthalmology, 2018 Purpose. To compare the qualitative and quantitative choroidal neovascularization (CNV) changes after antivascular endothelial growth factor (anti-VEGF) therapy in treatment-naïve and treated eyes with age-related macular degeneration (AMD) using optical
Alexandra Miere +11 more
doaj +2 more sources
Initial Pro Re Nata Brolucizumab for Exudative AMD: The PROBE Study. [PDF]
J Clin Med, 2021 The present study aimed to determine the efficacy and safety of pro re nata (PRN) intravitreal brolucizumab therapy for neovascular age-related macular degeneration (AMD) without a loading dose in the real-world setting.
Bilgic A +8 more
europepmc +2 more sources
The Impact of Interval between Recurrence and Reinjection in Anti-VEGF Therapy for Diabetic Macular Edema in Pro Re Nata Regimen [PDF]
Journal of Clinical Medicine, 2021 Yoshihiro Takamura +2 more
exaly +2 more sources
Clinical Ophthalmology, 2016 Raja Narayanan,1 Bhavik Panchal,1 Michael W Stewart,2 Taraprasad Das,1 Jay Chhablani,1 Subhadra Jalali,1 Mohd Hasnat Ali3 On behalf of MARVEL study group 1Smt.
Narayanan R +6 more
doaj +1 more source
Türk Oftalmoloji Dergisi, 2023 Objectives:To compare the functional and anatomical outcomes of ranibizumab and aflibercept monotherapies given according to a pro re nata (PRN) protocol in treatment-naive eyes with diabetic macular edema (DME) in a real-life clinical setting.Materials ...
Mahmut Kaya +5 more
doaj +1 more source
Real-World Outcomes of Anti-VEGF Treatment for Neovascular Age-Related Macular Degeneration in Turkey: A Multicenter Retrospective Study, Bosphorus Retina Study Group Report No: 1 [PDF]
Türk Oftalmoloji Dergisi, 2018 Objectives: To evaluate the real-world outcomes of intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment in neovascular age-related macular degeneration (nAMD) patients.
Abdullah Özkaya +23 more
doaj +1 more source
Practical Considerations of PRN Medicines Management: An Integrative Systematic Review
Frontiers in Pharmacology, 2022 Background and objectives: Highly widespread use of pro re nata (PRN) medicines in various healthcare settings is a potential area for improper medication prescription and administration leading to patient harm.
Abbas Mardani +5 more
doaj +1 more source
Comparison of Long-term Efficacy of Intravitreal Ranibizumab in Diabetic Retinopathy following Monthly vs Pro Re Nata vs Treat and Extend Protocol [PDF]
Journal of Clinical and Diagnostic Research, 2022 Introduction: Diabetic Retinopathy (DR) is a major complication of Diabetes Mellitus (DM), which remains a leading cause of visual loss in working age populations. The most common cause of vision loss in patients with DR is Diabetic Macular Oedema (DME).
Avik Dey Sarkar +3 more
doaj +1 more source
Gender-specific differences in nursing staff's administration patterns of 'pro re nata' medication: A prospective observational study. [PDF]
, 2018 Background: Pro re nata‘(PRN) medications are important parts of the management of critically ill patients. PRN medications are predominantly administered by nurses, and indications, frequencies and doses of PRN might be influenced by experience ...
Glasmeyer, Sabeth Wiebeke
core +1 more source
Anti-VEGF injection frequency correlates with visual acuity outcomes in pro re nata neovascular AMD treatment. [PDF]
Sci Rep, 2019 Clinical trials report substantial gains in visual acuity (VA) for eyes treated with intravitreal anti-VEGF for neovascular AMD (nAMD). In clinical reality, VA outcomes are more variable.
Wecker T +7 more
europepmc +2 more sources